Severe fetal valproate syndrome: Combination of complex cardiac defect, multicystic dysplastic kidney, and trigonocephaly

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 3, 2011, Pages 521-524

  Özkan, Hilal ^a   Çetinkaya, Merih ^a   Köksal, Nilgün ^a   Yapici, Şenay ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

complex congenital heart disease; Fetal valproate syndrome; multicystic dysplastic kidney; teratogenicity; trigonocephaly

Indexed keywords

VALPROIC ACID;

ABSENCE; ADULT; APGAR SCORE; ARACHNODACTYLY; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BODY HEIGHT; BRAIN MALFORMATION; CAMPTODACTYLY; CARDIOMEGALY; CASE REPORT; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; CRANIOFACIAL SYNOSTOSIS; DRUG INDUCED DISEASE; EBSTEIN ANOMALY; ENDOTRACHEAL INTUBATION; FACIES; FEMALE; FETAL VALPROATE SYNDROME; FETUS ECHOGRAPHY; FRONTAL BOSSING; FUNNEL CHEST; HEAD CIRCUMFERENCE; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE HYPERTROPHY; HIGH ARCHED PALATE; HUMAN; HYDROCEPHALUS; INFANT; KIDNEY HYPOPLASIA; LIMB DEFECT; LOW DRUG DOSE; LOW SET EAR; MESOCARDIA; MICROPHTHALMIA; MOUTH MALFORMATION; MULTICYSTIC DYSPLASTIC KIDNEY; MUSCLE HYPOTONIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; RESPIRATORY FAILURE; TERATOGENICITY; TRIGONOCEPHALY;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; CRANIOSYNOSTOSES; FATAL OUTCOME; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; LIMB DEFORMITIES, CONGENITAL; MULTICYSTIC DYSPLASTIC KIDNEY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEVERITY OF ILLNESS INDEX; VALPROIC ACID; YOUNG ADULT;

EID: 79751504241     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.501120     Document Type: Article

References (29)

1. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16:165-170. (Pubitemid 36521202)
2. Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, de Vigan C, Lancaster PA, Merlob P, Sumiyoshi Y, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000;41:1436-1443.
3. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-1138. (Pubitemid 32285234)
4. Lindhout D, Omtzigt JG. Pregnancy and the risk of teratogenicity. Epilepsia 1992;33:S41-S48.
5. Kini U. Fetal valproate syndrome: a review. Paed Perinat Drug Ther 2006;7:123-130. (Pubitemid 46010013)
6. Genton P, Semah F, Trinka E. Valproic acid in epilepsy. Drug Safety 2006;29:1-21.
7. DiLiberti JH, Farndon PA, Dennis NR, Curry CJ. The fetal valproate syndrome. Am J Med Genet 1984;19:473-481. (Pubitemid 15205835)
8. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry 2006;77:193-198.
9. Clayton-Smith J, Donnai D. Fetal valproate syndrome. J Med Genet 1995;32:724-727.
10. Lajeunie E, Barcik U, Thorne JA, Ghouzzi VE, Bourgeois M, Renier D. Craniosynostosis and fetal exposure to sodium valproate. J Neurosurg 2001;95:778-782. (Pubitemid 33043350)
11. Kozma CM. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet 2001;98:168-175.
12. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Seizure 2008;17:166-171.
13. Uziel D, Rozental R. Neurologic birth defects after prenatal exposure to antiepileptic drugs. Epilepsia 2008;49 (Suppl 9); 35-42.
14. Cetinkaya M, Ö zkan H, Kö ksal N. Unilateral radius aplasia due to lamotrigine and oxcarbazepine use in pregnancy. J Matern Fetal Neonatal Med 2008;21:927-930.
15. McElhatton P. Teratogenic drugs - part 1. Adverse Drug Reac Bull 2002;213:815-818. (Pubitemid 34601028)
16. Vajda FJ, O Brien TJ, Hitchcock A, Graham J, Cook M, Lander C, Eadie MJ. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004;11:854-858. (Pubitemid 39440564)
17. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46: 739-746. (Pubitemid 29518135)
18. Mawer G, Clayton-Smith J, Coyle H, Kini U. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 2002;11:512-518. (Pubitemid 35452869)
19. Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, Nakane Y, Ogawa Y, Avanzini G, Fumarola C, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-158. (Pubitemid 29143352)
20. Eadie MJ, Vajda FJ. Should valproate be taken during pregnancy? Ther Clin Risk Manag 2005;1:21-26.
21. Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratog Carcinog Mutagen 1996;16:97-108. (Pubitemid 26308969)
22. Sonoda T, Ohdo S, Ohba K, Okishima T, Kayakawa K. Sodium valproate- induced cardiovascular abnormalities in the Jc1: ICR mouse fetus: peak sensitivity of gestational age and dose dependent effect. Teratology 1993;48:127-132. (Pubitemid 23233589)
23. Sodhi P, Poddar P, Parmar V. Fetal cardiac malformation in fetal valproate syndrome. Indian J Pediatr 2001;68:989-990. (Pubitemid 33097982)
24. ten Berg K, van Oppen AC, Nikkels PG, Gittenberger-de Groot AC, van der Voet GB, Brilstra EH, Lindhout D. Complex cardiac defect with hypoplastic right ventricle in a fetus with valproate exposure. Prenat Diagn 2005;25:156-158.
25. Verloes A, Frikiche A, Gremillet C, Paquay T, Decortis T, Rigo J, Senterre J. Proximal phocomelia and radial ray aplasia in fetal valproic syndrome. Eur J Pediatr 1990;149:266-267. (Pubitemid 20031970)
26. Moore SJ, Turnperry PD, Quinn A, Glover S, Lloyd DJ, Montgomery T, Dean JC. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37: 489-497. (Pubitemid 30428234)
27. Lajeunie E, Le Merrer M, Marchac D, Renier D. Syndromal and nonsyndromal primary trigonocephaly: analysis of a series of 237 patients. Am J Med Genet 1998;75:211-215. (Pubitemid 28034504)
28. Kuciene R, Dulskiene V. Selected enviromental risk factors and congenital heart defects. Medicina (Kaunos) 2008;44: 827-832.
29. Hains DS, Bates CM, Ingraham S, Schwaderer AL. Management and etiology of the unilateral multicystic dysplastic kidney: a review. Pediatr Nephrol 2009;24:233-241.